Amino-substituted heterocycles as renin inhibitors
AssigneeWarner-Lambert Company
InventorsCleo Connolly, Annette Marion Doherty, Harriet Wall Hamilton, William Chester Patt, Ila Sircar
Life of this patent
Estimating the term…
Abstract
The invention concerns novel renin-inhibitory compounds which contain an amino-substituted heterocycle at the P.sub.2 position. These are useful for treating renin-associated hypertension, congestive heart failure, glaucoma, hyperaldosteronism, and diseases caused by retroviruses including HTLV-I and -III. Processes for preparing the compounds, compositions containing them, and methods of using them are included. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension, or hyperaldosteronism.
Claims24
A compound of the formula ##STR25## or a pharmaceutically acceptable acid addition salt thereof wherein A is BOC, BBSP, Z, ##STR26## wherein R and R.sub.1 are each independently hydrogen or straight or branched chain lower alkyl which is unsubstituted or substituted by one or two hydroxy, one or two amino groups, or ##STR27## wherein this is a saturated ring containing two to five carbon atoms wherein Q is CH.sub.2, O, S, or NR wherein R is as above;
- B is absent, PHE, TYR, or TYR(OME) with the proviso that when A is BBSP, B is absent;
- C is CST, FCS, FCO, CD is DH, or STA;
- D is absent, OH, or NR.sub.2 R.sub.3 wherein R.sub.2 and R.sub.3 are each independently hydrogen or straight or branched lower alkyl or when R.sub.2 is hydrogen, R.sub.3 can also be --(CH.sub.2).sub.m X wherein m is an integer of from zero to eight and X is --OH, ##STR28## as defined above, OR.sub.4, NR.sub.5 R.sub.6 wherein R.sub.4, R.sub.5, and R.sub.6 are each independently hydrogen, straight or branched chain lower alkyl substituted or unsubstituted by one or two hydroxy or amino groups with the proviso that when C is CAD, D is absent;
- E is hydrogen, Z, BOC, TROC, or lower alkanoyl,
- n is an integer of from 0 to 2;
- X and Y are each independently O, S, N or NH and at least one of X and Y must be N;
- X and
- Y cannot both be N.
A compound named SMO-PHE-(S)ATM-CAD.
A compound selected from the group consisting of:
- BOC-ATM(Z)-CAD and ATM(Z)-CAD.
A compound selected from the group consisting of:
- BOC-ATM(Z)-CST-AEM and ATM(Z)-CST-AEM.
A compound selected from the group consisting of:
- BOC-ATM(Z)-STA-MBA and ATM(Z)-STA-MBA.
A compound selected from the group consisting of:
- BOC-ATG(Z)-STA-MBA and ATG(Z)-STA-MBA.
A compound selected from the group consisting of:
- BOC-(S)ATM-OBZL-HCL and BOC-(S)ATE-OBZL.
A compound selected from the group consisting of:
- BOC-(S)ATM(Z)-CAD and (S)ATM(Z)-CAD.cndot.2HCl.
A compound selected from the group consisting of:
- BOC-(S)ATE(Z)-OBZL, BOC-(S)ATE(Z), and BOC-(S)ATE(Z)-CAD.
A compound selected from the group consisting of:
- BOC-ATG(Z)-CAD and ATG(Z)-CAD.cndot.HCl.
A compound selected from the group consisting of:
- BOC-(S)ATM(TROC)-FCS-AEM and (S)ATM(TROC)-FCS-AEM.
A compound selected from the group consisting of:
- BOC-(S)ATM(TROC)-OBZL, BOC-(S)ATM(TROC), and BOC-(S)ATM(TROC)-CAD.
A compound named BOC-(S)ATM(TROC)-CDH.
A compound selected from the group consisting of:
- SMO-PHE-(S)ATM(Z), (S)ATM(Z)-OBZL.cndot.HCl, and SMO-PHE-(S)ATM(Z)-OBZL.
A compound selected from the group consisting of:
- BOC-(S)ATM(TROC)-FCS-OET, (S)ATM(TROC)-FCS-OET, BOC-ATG(Z)-FCS-AEM, BOC-ATG(Z)-FCS-AEM, ATG(Z)-FCS-AEM (Isomer A), and ATG(Z)-FCS-AEM.
Dependencies are inferred from the claim text.